Powered by

Argos Therapeutics Announces Appointment of Richard Morrison, PhD to Board of Directors

Sep 26, 2017 - GlobeNewswire
Board and Executive Moves

DURHAM, N.C., Sept. 26, 2017 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (NASDAQ:ARGS), an immuno-oncology company focused on the development and commercialization of individualized immunotherapies based on the Arcelis® precision immunotherapy technology platform, today announced the appointment of Richard Morrison, PhD, to the Company's board of directors. Dr. Morrison will serve as a Class III director and will serve on the audit committee of the board of directors.

Dr. Morrison bri...